Follow The Filings

NECB

Earnings company data as of 11:58 AM ET 10/23

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 22 Oct EPS 0.82 — —
Rev — — —

Insider trades

Open-market buys and sales by NECB's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NECB insider trades
  • None no insider bought on the open market
  • $434K sold by 5 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Donald S Hom CFO
    Sale
    $82K 3,000 shares at $27.20 39% of stake
    Traded Jul 29 Filed Jul 29
  2. Charles Michael Cirillo Director
    Sale
    $82K 3,566 shares at $22.94 38% of stake
    Traded Mar 12 Filed Mar 13
  3. John F McKenzie Director
    Sale
    $72K 3,000 shares at $23.85 16% of stake
    Traded Mar 5 Filed Mar 6
  4. Diane B Cavanaugh Director
    Sale
    $24K 1,000 shares at $23.60 13% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
  5. Donald S Hom CFO
    Sale
    $48K 2,000 shares at $23.76 21% of stake
    Traded Dec 12, 2025 Filed Dec 12, 2025
  6. Charles A Martinek Director
    Sale
    $47K 2,000 shares at $23.47 80% of stake
    Traded Dec 11, 2025 Filed Dec 11, 2025
  7. Donald S Hom CFO
    Sale
    $81K 4,000 shares at $20.19
    Traded Oct 28, 2025 Filed Oct 29, 2025

Also filed in the last 12 months, not counted as buying or selling: 6 share withholdings for taxes, 2 other transactions, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 22 shown.

Filed Form Detail Links
8-K 2.02,9.01
10-Q
8-K 2.02,9.01
8-K 5.02,5.07
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A
10-K
8-K 2.02,9.01
8-K 5.02
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
8-K 8.01,9.01
10-Q
8-K 2.02,9.01
8-K 5.07,9.01
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.